List of Excipients in API anagrelide hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing anagrelide hydrochloride
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Takeda Pharmaceuticals America Inc | AGRYLIN | anagrelide hydrochloride | 54092-063 | ANHYDROUS LACTOSE | |
Takeda Pharmaceuticals America Inc | AGRYLIN | anagrelide hydrochloride | 54092-063 | CELLULOSE, MICROCRYSTALLINE | |
Takeda Pharmaceuticals America Inc | AGRYLIN | anagrelide hydrochloride | 54092-063 | CROSPOVIDONE | |
Takeda Pharmaceuticals America Inc | AGRYLIN | anagrelide hydrochloride | 54092-063 | LACTOSE MONOHYDRATE | |
Takeda Pharmaceuticals America Inc | AGRYLIN | anagrelide hydrochloride | 54092-063 | MAGNESIUM STEARATE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing anagrelide hydrochloride
Detailed excipient profiles for anagrelide hydrochloride
Excipient focus: ALUMINUM OXIDE
anagrelide hydrochloride drug variants containing ALUMINUM OXIDE
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
>Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing ALUMINUM OXIDE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
>Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
anagrelide hydrochloride drug variants containing ANHYDROUS LACTOSE
anagrelide hydrochloride drug variants not containing ANHYDROUS LACTOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
anagrelide hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
anagrelide hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
anagrelide hydrochloride drug variants containing CROSPOVIDONE
anagrelide hydrochloride drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
anagrelide hydrochloride drug variants containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
>Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
>Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
anagrelide hydrochloride drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
>Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
anagrelide hydrochloride drug variants containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
>Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
anagrelide hydrochloride drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
>Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
anagrelide hydrochloride drug variants containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
>Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
anagrelide hydrochloride drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
>Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
anagrelide hydrochloride drug variants containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
>Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
anagrelide hydrochloride drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
>Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN
anagrelide hydrochloride drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
>Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
>Company | >Ingredient | >NDC |
Excipient focus: INDIGOTINDISULFONATE SODIUM
anagrelide hydrochloride drug variants containing INDIGOTINDISULFONATE SODIUM
Company | Ingredient | NDC |
---|---|---|
Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
>Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing INDIGOTINDISULFONATE SODIUM
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
anagrelide hydrochloride drug variants containing LACTOSE MONOHYDRATE
anagrelide hydrochloride drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
anagrelide hydrochloride drug variants containing MAGNESIUM STEARATE
anagrelide hydrochloride drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
anagrelide hydrochloride drug variants containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
>Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
anagrelide hydrochloride drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
>Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
anagrelide hydrochloride drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
>Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
>Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
anagrelide hydrochloride drug variants containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
>Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
anagrelide hydrochloride drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | anagrelide hydrochloride | 0172-5241 |
Physicians Total Care Inc | anagrelide hydrochloride | 54868-5443 |
Carilion Materials Management | anagrelide hydrochloride | 68151-2959 |
>Company | >Ingredient | >NDC |
anagrelide hydrochloride drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | anagrelide hydrochloride | 54092-063 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.